Formulation first.

Synthesis to specification

Peptide raw material is bought against a written purity specification with a stated impurity profile, not accepted on a supplier certificate alone.

Independent lot testing

Finished lots go to an independent laboratory for identity, purity and potency, plus a contaminant panel matched to the format.

Full excipient disclosure

Actives with amounts, every other ingredient named, capsule material stated. No proprietary blends.

Traceable to the lot

Every finished unit traces back to the raw material lots it came from, which is what makes a recall bounded rather than theoretical.

What we will say

• The exact form and salt of every active, and why it was chosen.
• The dose per serving and the basis that figure is stated on.
• The route of administration and what it implies for absorption.
• Where evidence is preclinical, in those words.

What we will not say

• That a supplement treats, cures or prevents any disease.
• That an oral capsule is equivalent to a prescription injection.
• That an animal study predicts a human outcome.
• That a product is FDA approved, which no supplement is.